Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/18967Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Pamecha, V. | en |
| dc.contributor.author | Nedjat-Shokouhi, B. | en |
| dc.contributor.author | Gurusamy, K. | en |
| dc.contributor.author | Glantzounis, G. K. | en |
| dc.contributor.author | Sharma, D. | en |
| dc.contributor.author | Davidson, B. R. | en |
| dc.date.accessioned | 2015-11-24T18:56:00Z | - |
| dc.date.available | 2015-11-24T18:56:00Z | - |
| dc.identifier.issn | 1421-9883 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/18967 | - |
| dc.rights | Default Licence | - |
| dc.subject | Adult | en |
| dc.subject | Aged | en |
| dc.subject | Antineoplastic Combined Chemotherapy Protocols/therapeutic use | en |
| dc.subject | Chemotherapy, Adjuvant | en |
| dc.subject | Colorectal Neoplasms/*pathology/*therapy | en |
| dc.subject | *Embolization, Therapeutic | en |
| dc.subject | Female | en |
| dc.subject | Hepatectomy/*methods | en |
| dc.subject | Humans | en |
| dc.subject | Liver Neoplasms/*secondary/surgery/*therapy | en |
| dc.subject | Male | en |
| dc.subject | Middle Aged | en |
| dc.subject | *Portal Vein | en |
| dc.subject | Prospective Studies | en |
| dc.subject | Survival Analysis | en |
| dc.subject | Treatment Outcome | en |
| dc.title | Prospective evaluation of two-stage hepatectomy combined with selective portal vein embolisation and systemic chemotherapy for patients with unresectable bilobar colorectal liver metastases | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.primary | 10.1159/000176063 | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/19033722 | - |
| heal.identifier.secondary | http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=000176063&Ausgabe=240353&ProduktNr=223996&filename=000176063.pdf | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2008 | - |
| heal.abstract | BACKGROUND: Liver resection is contraindicated in patients with multiple bilobar colorectal liver metastases because of the small liver remnant. An alternative strategy which may be curative is a two-stage hepatectomy in which the cancer is resected from one lobe and regeneration allowed prior to contralateral lobe resection. OBJECTIVE: To assess the feasibility, risks, and outcomes in a prospectively applied strategy for two-stage hepatectomy. METHODS: Over a 6-year period, 14 of 280 patients undergoing liver resection for colorectal liver metastases (5%) were considered for two-stage hepatectomy. Surgery was combined with chemotherapy in all (n = 14) and portal vein embolisation (PVE) selectively (n = 5). Median follow-up was 43 months. RESULTS: Both stages were completed in 11 of 14 patients (78%). There were no deaths. Post-operative complication rates were 0% (1st hepatectomy) and 27% (2nd hepatectomy). The 5-year survival after the second hepatectomy was 50%. The mean disease-free survival was 25 +/- 7.5 months. CONCLUSION: Two-stage hepatectomy combined with systemic chemotherapy and PVE can produce long-term survival in patients with multiple bilobar colorectal liver metastases. | en |
| heal.journalName | Dig Surg | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Pamecha-2008-Prospective evaluati.pdf | 195.75 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
